Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Wegovy is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Ordering three vials every 1215 weeks instead of one vial every 5 weeks reduces shipping frequency by two-thirds while maintaining the same per-dose cost
PMID: Summary Keywords GIP/GLP-1 receptor agonist, glucagon-like peptide 1 receptor agonist, glucocorticosteroids, semaglutide, steroid-induced diabetes, steroid-induced hyperglycaemia Citation Jdrasek A, Lisowska K and Czupryniak L (2026) Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review
The modulator binds high in the helical bundle at an interface between TM1 and TM2, allowing access to the peptide ligand
US$ 25.46
US$ 29.74
US$ 25.52
US$ 26.43
US$ 20.39
